Skip to main content

Predictors of agr dysfunction in methicillin-resistant Staphylococcus aureus (MRSA) isolates among patients with MRSA bloodstream infections.

Publication ,  Journal Article
Butterfield, JM; Tsuji, BT; Brown, J; Ashley, ED; Hardy, D; Brown, K; Forrest, A; Lodise, TP
Published in: Antimicrob Agents Chemother
December 2011

Despite emerging evidence that dysfunction in the accessory gene regulator (agr) locus is associated with deleterious outcomes among patients treated with vancomycin for methicillin-resistant Staphylococcus aureus (MRSA) infections, factors predictive of agr dysfunction have not been evaluated. This study describes the epidemiology of agr dysfunction, identifies predictors of agr dysfunction in MRSA isolates among those with MRSA bloodstream infections, and describes the relationship between agr dysfunction and other microbiologic phenotypes. A cross-sectional study of patients with MRSA bloodstream infections at two institutions in upstate New York was performed. Clinical data on demographics, comorbidities, disease severity, hospitalization history, and antibiotic history were collected. Microbiologic phenotypes, including agr dysfunction, MIC values by broth microdilution (BMD) and Etest, and vancomycin heteroresistance (hVISA) were tested. Multivariable analyses were performed to identify factors predictive of agr dysfunction. Among 200 patients with an MRSA bloodstream infection, the proportion of strains with agr dysfunction was 31.5%. The distribution of MICs determined by both BMD and Etest were equivalent across agr groups, and there was no association between agr dysfunction and the presence of hVISA. Severity of illness, comorbidities, and hospitalization history were comparable between agr groups. In the multivariate analysis, prior antibiotic exposure was the only factor of variables studied found to be predictive of agr dysfunction. This relationship was predominantly driven by prior beta-lactam and fluoroquinolone administration in the bivariate analysis. Identifying these institution-specific risk factors can be used to develop a process to assess the risk of agr dysfunction and guide empirical antibiotic therapy decisions.

Duke Scholars

Published In

Antimicrob Agents Chemother

DOI

EISSN

1098-6596

Publication Date

December 2011

Volume

55

Issue

12

Start / End Page

5433 / 5437

Location

United States

Related Subject Headings

  • beta-Lactams
  • Vancomycin Resistance
  • Vancomycin
  • Staphylococcal Infections
  • Risk Factors
  • New York
  • Middle Aged
  • Microbiology
  • Microbial Sensitivity Tests
  • Methicillin-Resistant Staphylococcus aureus
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Butterfield, J. M., Tsuji, B. T., Brown, J., Ashley, E. D., Hardy, D., Brown, K., … Lodise, T. P. (2011). Predictors of agr dysfunction in methicillin-resistant Staphylococcus aureus (MRSA) isolates among patients with MRSA bloodstream infections. Antimicrob Agents Chemother, 55(12), 5433–5437. https://doi.org/10.1128/AAC.00407-11
Butterfield, Jill M., Brian T. Tsuji, Jack Brown, Elizabeth Dodds Ashley, Dwight Hardy, Kristen Brown, Alan Forrest, and Thomas P. Lodise. “Predictors of agr dysfunction in methicillin-resistant Staphylococcus aureus (MRSA) isolates among patients with MRSA bloodstream infections.Antimicrob Agents Chemother 55, no. 12 (December 2011): 5433–37. https://doi.org/10.1128/AAC.00407-11.
Butterfield JM, Tsuji BT, Brown J, Ashley ED, Hardy D, Brown K, et al. Predictors of agr dysfunction in methicillin-resistant Staphylococcus aureus (MRSA) isolates among patients with MRSA bloodstream infections. Antimicrob Agents Chemother. 2011 Dec;55(12):5433–7.
Butterfield, Jill M., et al. “Predictors of agr dysfunction in methicillin-resistant Staphylococcus aureus (MRSA) isolates among patients with MRSA bloodstream infections.Antimicrob Agents Chemother, vol. 55, no. 12, Dec. 2011, pp. 5433–37. Pubmed, doi:10.1128/AAC.00407-11.
Butterfield JM, Tsuji BT, Brown J, Ashley ED, Hardy D, Brown K, Forrest A, Lodise TP. Predictors of agr dysfunction in methicillin-resistant Staphylococcus aureus (MRSA) isolates among patients with MRSA bloodstream infections. Antimicrob Agents Chemother. 2011 Dec;55(12):5433–5437.

Published In

Antimicrob Agents Chemother

DOI

EISSN

1098-6596

Publication Date

December 2011

Volume

55

Issue

12

Start / End Page

5433 / 5437

Location

United States

Related Subject Headings

  • beta-Lactams
  • Vancomycin Resistance
  • Vancomycin
  • Staphylococcal Infections
  • Risk Factors
  • New York
  • Middle Aged
  • Microbiology
  • Microbial Sensitivity Tests
  • Methicillin-Resistant Staphylococcus aureus